| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |